Method Article

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

7.4K views

DOI:

10.3791/55027

February 20th, 2017

In This Article

Summary

In this paper, we report a protocol describing an in vivo method to measure microtubule dynamic instability in docetaxel-resistant breast cancer cells (MCF-7TXT). In this method, a deconvolution microscopy imaging system is used to detect the expression of GFP-tubulin in target cells.

Abstract

Taxanes such as docetaxel belong to a group of microtubule-targeting agents (MTAs) that are commonly relied upon to treat cancer. However, taxane resistance in cancerous cells drastically reduces the effectiveness of the drugs' long-term usage. Accumulated evidence suggests that the mechanisms underlying taxane resistance include both general mechanisms, such as the development of multidrug resistance due to the overexpression of drug-efflux proteins, and taxane-specific mechanisms, such as those that involve microtubule dynamics.

Because taxanes target cell microtubules, measuring microtubule dynamic instability is an important step in determining the mechanisms of taxane resistance and provides insight into how to overcome this resistance. In the experiment, an in vivo method was used to measure microtubule dynamic instability. GFP-tagged α-tubulin was expressed and incorporated into microtubules in MCF-7 cells, allowing for the recording of the microtubule dynamics by time lapse using a sensitive camera. The results showed that, as opposed to the non-resistant parental MCF-7CC cells, the microtubule dynamics of docetaxel-resistant MCF-7TXT cells are insensitive to docetaxel treatment, which causes the resistance to docetaxel-induced mitotic arrest and apoptosis. This paper will outline this in vivo method of measuring microtubule dynamic instability.

Introduction

The leading cause of breast cancer mortality is through metastasis1,2. Taxanes, such as docetaxel and paclitaxel, are currently used as first-line regimens in the treatment of metastatic breast cancer2,3,4,5,6. They are part of a group of microtubule-targeting agents (MTAs) that disrupt microtubule dynamics. However, one of the greatest challenges to using taxanes in curative therapy is the development of taxane resistance in cancer cells, which lea....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparing the Cells for Live Imaging

  1. Cell culture and seeding
    1. Use MCF-7 breast cancer cells selected for resistance to docetaxel (MCF-7TXT) and their non-resistant parental cell line (MCF-7CC). The detailed selection process and the characterization of these selected cell lines were described previously24.
    2. Grow all cells in 10 cm culture dishes at 37 °C in a medium composed 90% of Dulbecco's modified Eagle's medium (DMEM) and 10% of fetal bovine serum (FBS) and supplemented with non-essential amino acids. Maintain the medium in a 5% CO2 atmosphere. Maintain ....

Access restricted. Please log in or start a trial to view this content.

Results

Using the protocol presented here, we studied the effects of docetaxel on the microtubule dynamics of normal (MCF-7CC) and docetaxel-resistant (MCF-7TXT) breast cancer cells. Two sets of images show the effects of docetaxel (0.5 µM) on microtubule growth and shortening in MCF-7CC and MCF-7TXT cells (Figure 1A).

We also calculated the rate of microtubule growth or short.......

Access restricted. Please log in or start a trial to view this content.

Discussion

There are two major methods to measure microtubule dynamic instability: in vitro and in vivo. In the in vitro method, purified tubulin is used to measure microtubule dynamic instability with computer-enhanced time-lapse differential interference-contrast microscopy. In the in vivo method, microinjected fluorescent tubulin, or expressed GFP-tubulin, is incorporated into microtubules. The dynamics (growth and shortening) of the microtubules is then recorded by time-lapse using a sensitiv.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no competing financial interests.

Acknowledgements

This research is supported by funding from CBCF (to ZW).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Dulbecco's Modified Eagle's Medium (DMEM)Sigma-AldrichD5796
Non-essential amino acidsLife Technologies, Invitrogen11140-050
FBSGibco, Invitrogen12483
Anti-Anti (100x)Life Technologies, Invitrogen15240-062
docetaxelSigma-Aldrich01885-5mg-F
DMEM phenol red-freeGibco, Invitrogen21063
CellLight Reagent *BacMam 2.0* GFP-tubulinThermoFisher ScientificC10613Key reagent for expressing GFP tubulin in cells
CellLight Reagent *BacMam 2.0* GFPThermoFisher ScientificB10383Control
Dimethyl Sulfoxide (DMSO)Sigma-Aldrich+B9:AA9472301for dissoving decetaxel
22-mm glass coveslipFisher Scientifics12-545-101
6-well culture plateGreiner Bio-One International6 Well Celi Culture Plate
DeltaVision Microscopy Imaging SystemsGE HealthThis system is equipped with weather station for controlling temperature and CO2. It also equipped with Worx Software for deconvolution and time lapse control.
Trypsin-EDTA (0.25%), phenol redThermoFisher Scientific25200056
Bright-Line Hemacytometer Set, Hausser ScientificHausser Scientific, Distributed by VWRSupplier No.: 1492 VWR No.:15170-172

References

  1. Kamangar, F., Dores, G. M., Anderson, W. F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 24 (14), 2137-2150 (2006).
  2. Yardley, D. A.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Docetaxel Resistant CellsGFP tagged Alpha TubulinTime Lapse ImagingFluorescence MicroscopyMicrotubule GrowthMicrotubule ShorteningIn Vivo MethodBreast Cancer CellsDrug Treatment

Related Articles